Sponsor
1 Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia Journal of Clinical Oncology, May 9, 2013
2 Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS hydromorphone extended release in opioid-tolerant patients with chronic low back pain Journal of Pain Research, May 7, 2013
3 Survey of European patients assessing their own noncancer chronic pain: results from Spain Current Medical Research and Opinion, May 20, 2013 Review Article
4 The correlations of sexual activity, sleep problems, emotional distress, attachment styles with quality of life: comparison between gynaecological cancer survivors and noncancer women Journal of Clinical Nursing, May 13, 2013
5 Noncancer pain conditions and risk of suicide JAMA Psychiatry, May 23, 2013
6 Pain conditions among veterans with schizophrenia or bipolar disorder General Hospital Psychiatry, May 2, 2013
7 Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain Clinical Therapeutics, May 22, 2013 Review Article
8 Opioid Use for Noncancer Pain and Risk of Fracture in Adults: A Nested Case-Control Study Using the General Practice Research Database American Journal of Epidemiology, May 7, 2013
9 Intrathecal Infusion Systems for Long-Term Management of Chronic Non-Cancer Pain: An Update of Assessment of Evidence Pain Physician, May 6, 2013 Evidence Based Medicine Review Article
10 Identifying serum biomarkers for ovarian cancer by screening with surface-enhanced laser desorption/ionization mass spectrometry and the artificial neural network International Journal of Gynecological Cancer, May 3, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor